GRECLAV 625 MG (AMOXICILLIN 500 MG + CLAVULANIC ACID 125 MG) TABLETS USP
GRECLAV 625 MG (AMOXICILLIN 500MG + CLAVULANATE POTASSIUM 125 MG) TABLETS USP.
NAFDAC REG. NUMBER: B4-3680
COMPOSITION: Each film- coated tablet contains 500 mg of Amoxicillin as Amoxicillin Trihydrate U.S.P and 125 mg of Clavulanic Acid as Clavulanate Potassium U.S.P
PRODUCT PACKAGING: 14 white, oblong-shaped tablets in Alu-Alu blisters (2 blisters of 7 tablets)
INDICATIONS:
Greclav is indicated for the treatment of the following infections in adults and children
• Lower Respiratory Infections: Caused by ß-Iactamase-producing strains of H. influenzae and M. catarrhalis.
• Upper Respiratory tract infections e.g.,
Otitis Media: Caused by ß-Iactamase-producing strains of H. influenzae and M. catarrhalis.
Sinusitis: Caused by ß-Iactamase-producing strains of H. influenzae and M. catarrhalis
Skin and Skin Structure Infections: Caused by ß-Iactamase-producing strains of S. aureus, E. coli & Klebsiella spp.
Urinary Tract Infections: Caused by ß-Iactamase-producing strains of E. coli, Klebsiella spp., and Enterobacter spp. Bone and Joint Infections e.g., osteomyelitis.
Additional Information
BENEFITS
For infections caused by beta-lactamase producing gram-positive and gram-negative amoxicillin sensitive becteria such as:
- H.Pylori gut infections
- Pneumonia
- Urinary tract infections
- Sexually-transmitted diseases
- Skin & tissue infections
- Acute & chronic otitis media
CONSULT YOUR PHYSICIAN BEFORE USING THIS MEDICINE.
KEEP ALL MEDICINES OUT OF REACH OF CHILDREN!
MANUFACTURED BY: MEDICEF PHARMA FOR GREEN HOPE HEALTH CARE LIMITED